Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
Status: | Terminated |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 5/26/2018 |
Start Date: | May 2015 |
End Date: | June 16, 2016 |
Comparison of Unfractionated Heparin and Bivalirudin for Percutaneous Coronary Intervention for Stable Angina, Unstable Angina, and Non-ST Segment Elevation Myocardial Infarction
The purpose of this trial is to determine whether bivalirudin is non-inferior to
unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment
elevation myocardial infarction undergoing percutaneous coronary intervention.
unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment
elevation myocardial infarction undergoing percutaneous coronary intervention.
Inclusion Criteria:
1. Undergoing PCI for stable angina, unstable angina, or non-ST segment elevation
myocardial infarction.
2. Age 18 years or older.
Exclusion Criteria:
1. Inability to obtain consent
2. Emergency cardiac catheterization for ST-segment elevation myocardial infarction.
We found this trial at
1
site
4733 Sunset Blvd
Los Angeles, California 90027
Los Angeles, California 90027
(800) 954-8000
Kaiser Permanente Los Angeles Medical Center We've been there for you in the past, providing...
Click here to add this to my saved trials